Rare diseases
Investigational molecules
Locations
Back to Italy184 clinical trials in Chieti, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis
ItalyStudy of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma
ItalyStudy Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments
ItalyStudy Comparing Bimatoprost Eye Drops with Lumigan for Patients with Chronic Open-Angle Glaucoma or Ocular Hypertension
ItalyStudy on the Effects of RGX-314 Gene Therapy Compared to Aflibercept and Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration
ItalyStudy on the Safety and Effectiveness of Baricitinib and Tocilizumab for Children with Systemic Juvenile Idiopathic Arthritis
ItalyStudy on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency
ItalyStudy on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis
ItalyStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations
ItalyStudy on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy
ItalyStudy on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes
ItalyStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple sclerosis treatments and management of Parkinson's disease. Clinical trials are evaluating new therapeutic approaches including frexalimab for relapsing MS and novel subcutaneous infusion therapies for advanced Parkinson's.
Comprehensive studies examining treatments for type 2 diabetes and cardiovascular conditions. Research includes evaluation of tirzepatide and innovative approaches for stroke prevention in patients with atrial fibrillation.
Advanced research in chronic kidney disease and end-stage renal disease, investigating novel dialysis solutions and treatment combinations. Studies focus on improving outcomes for patients requiring peritoneal dialysis.
Clinical investigations of treatments for atopic dermatitis and other skin conditions. Studies evaluate new biological therapies and targeted treatments for various dermatological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
